Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384171 · ClinicalTrials.gov registry record · NA

Develop and Validation of Measurement-Based Transition Assistance

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT05384171: Completed NA study, sponsored by VA Office of Research and Development.

NCT05384171 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384171, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

Although some Veterans seek help when they experience post-military readjustment challenges, many do not. One factor that stands in the way of Veterans' willingness to seek help for these challenges is their lack of knowledge, both with regard to how severe challenges must be to warrant help-seeking and what resources are available to address these challenges. Measurement-Based Transition Assistance (MBTA) aims to address these barriers to help-seeking by providing Veterans with individualized feedback on areas in which they would benefit from additional support with regard to their health, vocational, financial, and social circumstances, along with personalized recommendations for relevant programs, services, and supports. If effective, this scalable, population-based intervention strategy could be used independently or in conjunction with other approaches to enhancing Veterans' help-seeking to interrupt high-risk trajectories before they lead to chronic maladjustment and increased risk for suicide.

Interventions

  • BEHAVIORAL Measurement-Based Transition Assistance (MBTA)

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2022-11-03
Est. Completion 2023-06-26
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05384171

The ClinicalTrials.gov registry entry for NCT05384171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Measurement-Based Transition Assistance (MBTA) is the first listed.

NCT05384171 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05384171 about?

NCT05384171 is a clinical study titled "Develop and Validation of Measurement-Based Transition Assistance". Although some Veterans seek help when they experience post-military readjustment challenges, many do not. One factor that stands in the way of Veterans' willingness to seek help for these challenges is their lack of knowledge, both with regard to how severe challenges must be to warrant help-seeking...

What is the current status of trial NCT05384171?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-11-03. Estimated completion is 2023-06-26.

What interventions are being tested in trial NCT05384171?

The interventions under investigation include: Measurement-Based Transition Assistance (MBTA) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05384171?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.